Nelson Dusetti
May 5, 2025, 14:24
Nelson Dusetti: Advancing Pancreatic Cancer Research with ARARD Foundation
Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“Tumor plasticity and resistance remain major barriers in pancreatic cancer treatment. Thanks to the support of the ARARD Foundation – Home Care Provider, our team is advancing research to better understand and overcome these challenges. This grant supports and strengthens the work of two early-career researchers: Brice Chanez, clinical oncologist at Paoli-Calmettes Institute, and Nicolas Fraunhoffer Ph.D., translational researcher at CRCM – Cancer Research Centre of Marseille. This project relies on the Pancreas-View transcriptomic signature to molecularly stratify pancreatic tumors and uncover key mechanisms of treatment adaptation, plasticity and resistance – paving the way for more personalized therapies.”
More posts featuring Nelson Dusetti.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 5, 2025, 13:42
May 5, 2025, 13:40
May 5, 2025, 13:18
May 5, 2025, 12:53